Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial - Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
- About
COSM 
Cosmos Health Inc. (COSM)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- 1Y
- 1M
- 1W
Upturn Advisory Summary
12/05/2025: COSM (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
1 Analysts rated it
Very few follow this stock; limited insights, higher-risk early investing.
1 Year Target Price $3
1 Year Target Price $3
| 0 | Strong Buy |
| 1 | Buy |
| 0 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit 4.39% | Avg. Invested days 33 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  2.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 12/05/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 16.12M USD | Price to earnings Ratio - | 1Y Target Price 3 |
Price to earnings Ratio - | 1Y Target Price 3 | ||
Volume (30-day avg) 1 | Beta 4.4 | 52 Weeks Range 0.28 - 1.32 | Updated Date 12/5/2025 |
52 Weeks Range 0.28 - 1.32 | Updated Date 12/5/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -0.77 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Earnings Date
Report Date 2025-11-18 | When - | Estimate - | Actual -0.1748 |
Profitability
Profit Margin -31.01% | Operating Margin (TTM) -10.63% |
Management Effectiveness
Return on Assets (TTM) -13.03% | Return on Equity (TTM) -63.82% |
Valuation
Trailing PE - | Forward PE 52.63 | Enterprise Value 37290795 | Price to Sales(TTM) 0.27 |
Enterprise Value 37290795 | Price to Sales(TTM) 0.27 | ||
Enterprise Value to Revenue 0.66 | Enterprise Value to EBITDA -1.6 | Shares Outstanding 34919920 | Shares Floating 26109624 |
Shares Outstanding 34919920 | Shares Floating 26109624 | ||
Percent Insiders 25.23 | Percent Institutions 8.02 |
Upturn AI SWOT
Cosmos Health Inc.
Company Overview
History and Background
Cosmos Health Inc., formerly known as Cosmos Holdings Inc., is a global healthcare group involved in pharmaceutical distribution, own-brand products, and e-commerce. The company has evolved from its roots as a pharmaceutical distributor to include development and sales of its own products.
Core Business Areas
- Pharmaceutical Distribution: Distribution of branded and generic pharmaceuticals, over-the-counter (OTC) medicines, and healthcare products to pharmacies, hospitals, and wholesalers.
- Own-Brand Products: Development, manufacturing, and marketing of its own range of healthcare products, including dietary supplements, vitamins, and skincare items. These products are sold under the 'Sky Premium Life' and other brands.
- E-commerce: Online sales of pharmaceutical and healthcare products directly to consumers through various e-commerce platforms.
Leadership and Structure
Details regarding the specific individuals holding key leadership roles (CEO, CFO, etc.) and the organizational structure are available on the Cosmos Health Inc. investor relations website. The structure generally involves a board of directors overseeing various functional departments.
Top Products and Market Share
Key Offerings
- Competitors: Nature's Bounty,GNC,Nutrabolt
- Sky Premium Life: A range of own-brand dietary supplements, vitamins, and skincare products. Market share information is not readily available. Competitors include Nature's Bounty, GNC, and other supplement brands. Revenue contribution is unavailable.
- Competitors: McKesson,Cardinal Health,AmerisourceBergen
- Pharmaceutical Distribution: Distribution of various pharmaceutical products. Market share varies by region and product category. Competitors include McKesson, Cardinal Health, and AmerisourceBergen. Revenue Contribution not available.
Market Dynamics
Industry Overview
The pharmaceutical distribution and healthcare products market is highly competitive and regulated, with increasing demand for generic drugs, OTC products, and dietary supplements. E-commerce is also playing a significant role.
Positioning
Cosmos Health Inc. aims to differentiate itself through its own-brand products and strategic partnerships within its distribution network. They are positioned as a global provider focusing on both traditional and emerging markets.
Total Addressable Market (TAM)
The global pharmaceutical market is estimated to be in the trillions of USD. The Dietary Supplement and Skincare market is in the hundreds of billions of USD. Cosmos Health Inc. has a small percentage of the TAM, but intends to grow through acquistions and expand their existing distribution channels.
Upturn SWOT Analysis
Strengths
- Global distribution network
- Own-brand product portfolio
- E-commerce presence
- Ability to acquire
Weaknesses
- Small market share
- Limited brand recognition compared to competitors
- Financial Instability
- High debt levels
Opportunities
- Expanding into new geographic markets
- Acquiring smaller companies
- Increasing online sales
- Developing innovative products
Threats
- Intense competition
- Regulatory changes
- Economic downturns
- Supply chain disruptions
Competitors and Market Share
Key Competitors
- JNJ
- PFE
- MRK
- ABBV
- BMY
- MCK
- CAH
- ABC
Competitive Landscape
Cosmos Health Inc. faces significant competition from larger, more established players. Its advantage lies in its global distribution network and own-brand products, but it needs to further build brand recognition and scale its operations.
Major Acquisitions
Bahamas Medical Technologies Enterprises Corp.
- Year: 2023
- Acquisition Price (USD millions): 14.5
- Strategic Rationale: Expand operations into The Bahamas, providing more global growth opportunities.
Growth Trajectory and Initiatives
Historical Growth: Historical growth trends need to be derived from financial statements and growth rate is unavailable.
Future Projections: Analyst estimates for future growth require specific sources and data, currently unavailable.
Recent Initiatives: Recent strategic initiatives include acquisitions and partnerships to expand its product portfolio and distribution network.
Summary
Cosmos Health Inc. is a small player in a highly competitive market. While its global distribution network and own-brand products offer some advantages, it faces challenges in building brand recognition and competing with larger rivals. Acquisitions can boost growth, but financial stability and efficient operations are crucial for long-term success. The company needs to address its debt levels and improve its financial performance to enhance its competitiveness.
Similar Stocks
Sources and Disclaimers
Data Sources:
- Company Website
- SEC Filings
- Market Research Reports
Disclaimers:
The information provided is for informational purposes only and should not be considered financial advice. Market data is dynamic and subject to change. The AI-based rating is an estimate and should not be the sole basis for investment decisions.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Cosmos Health Inc.
Exchange NASDAQ | Headquaters Chicago, IL, United States | ||
IPO Launch date 2012-10-11 | Chairman & CEO Mr. Grigorios Siokas | ||
Sector Healthcare | Industry Medical Distribution | Full time employees 149 | Website https://www.cosmoshealthinc.com |
Full time employees 149 | Website https://www.cosmoshealthinc.com | ||
Cosmos Health Inc. manufactures, develops, and trades branded nutraceutical products in Greece, Croatia, Bulgaria, the United Arab Emirates, the United Kingdom, and Cyprus. The company offers prescription medications, over-the-counter drugs, medical devices, food supplements, nutraceuticals, cosmetics and other healthcare products under the Sky Premium Life and Mediterranation brand names. It also provides ASTO-CHOL (Pravastatin), Diorium (Omeprazole), HEART-FREE (Clopidogrel), LIPICHOL (Atorvastatin), Miltus (Donepezil), Newzypra (Olanzapine), PNEUMO-KAST (Montelukast), Sahar (Pioglitazone), VIVALCID (Leucovorin), and Diabit-is (Sitagliptin). In addition, the company offers branded biocides and antiseptic soaps under the C-Sept and C-Scrub brand names; and other pharmaceutical products include Melatonin Spray, used to reduce insomnia and jet lag; Otikon ear drops, which is a Class II medical device in the form of ear drops; and baby foods, such as organic powder milk, pasta with minced meat, whole grain rice cereals, whole grain cereal porridges, and organic rice creams with vanilla milk, as well as pear, carrot and banana purée under the Bio-bebe brand. It serves wholesalers and retail healthcare providers. Cosmos Health Inc. was incorporated in 2009 and is headquartered in Chicago, Illinois.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.